This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: Riches in Cheap Threads

Click here for an archive of Cramer's "Mad Money" Recaps.


TJX Companies (TJX), which owns T.J. Maxx and Marshalls, is as cheap as its clothes, said Jim Cramer on his "Mad Money" TV show Monday, and he wants you to buy the stock.

Cramer has been bearish on retail, but said it's time to start looking for retailers that have bottomed. TJX fits the bill.

TJX lowered earnings estimates last week, which is bullish for the stock, he said, because TJX now has reasonable earnings estimates it can meet or beat. That's the first step for a stock to bottom, he said.

What's more, the company is hosting a conference call Tuesday to update its strategic outlook. If the call goes well, Cramer believes it could get the stock moving.

Third, TJX should benefit from a slowdown in the economy because people tend to shop more at T.J. Maxx and Marshalls when they don't feel as affluent.

Fourth, the company's former CEO, Ben Cammarata, and former senior executive, Carol Meyrowitz, are back running the company. Cramer is a big fan of both.

Finally, Cramer believes TJX should be able to sell some of its standalone retail stores such as Bob's Stores, A.J. Wright or HomeGoods to an "eager and willing private-equity market."

TJX is a "safe and smart" buy here, said Cramer. The company's shares ended the regular trading session Monday at $21.60.

Commenting on online retailers, Cramer said he would be buying Amazon.com (AMZN), thinking it will do better because of high gasoline prices. Cramer would look to sell Amazon into potential future upgrades of the stock.

As for traditional retailers, Cramer likes Kohl's (KSS) and J.C. Penney (JCP) because they're down so much. He also likes Wal-Mart (WMT) because it is too low, he said, adding he wished he owned the stock.

BioCryst Pharma as Bird Flu Play

Cramer is bullish on BioCryst Pharmaceuticals (BCRX) for a trade because of the company's very early-stage vaccine for avian flu, Peramivir. The stock is risky, he said, because Peramivir is only in preclinical testing, and the drug has already been through an unsuccessful phase III study in 2003, said Cramer. Nevertheless, trading is all about the buzz, he said. "Wall Street's a fashion show. You want to buy the fashions before they become fashionable. When you see everybody wearing it, you want to sell it."

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,048.93 -22.29 -0.13%
S&P 500 1,969.75 -8.05 -0.41%
NASDAQ 4,487.3880 -18.4640 -0.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs